Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Double-Masked Phase 3 Study of Latanoprostene Bunod versus Timolol in Open-Angle Glaucoma
2013-000553-45Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of latanoprostene bunod in open-angle glaucoma (OAG) (2 arms), sponsored by Bausch + Lomb. Primary endpoint: Mean intraocular pressure in study eye. Started Jun 2013; status: completed.
02
Drugs
latanoprostene bunod
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on 2013-000553-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000553-45.